Older Age May Increase CKD Risk in Live Kidney Donors
Older age and hypertension increase the risk of renal impairment among live kidney donors, according to South Korean researchers.
Diagnosis & Disease Information
Ethanol May Ease Secondary Hyperparathyroidism Post-Tx
Percutaneous ethanol injection therapy (PEIT) is a useful and safe treatment alternative for patients with persistent post-transplant secondary hyperparathyroidism, researchers in Argentina report.
Researchers Identify New Fungal Threat
CHICAGO—Zygomycosis, an invasive fungal infection with substantial morbidity and mortality, is increasing steadily in the United States among solid organ and stem cell transplant recipients, according to the largest prospective study looking at contemporary cases.
Treatment Manages CMV in Transplant Recipients
Preemptive ganciclovir treatment of cytomegalovirus (CMV) infection in simultaneous pancreas-kidney (SPK) transplant recipients appears to be associated with good long-term outcomes, German researchers report.
Canadian Renal Transplant Data Show Race Disparities
Among Canadian dialysis patients, those of East Asian and Indo Asian origin are less likely to receive a renal transplant than white patients, data show.
Renal Transplant Patients May Need Vitamin D
BARCELONA—Most renal transplant patients in Denmark have inadequately low vitamin D levels, according to researchers who say routine supplementation may be required to mitigate the adverse clinical consequences.
RLS and Mortality Linked
Restless leg syndrome (RLS) is an independent predictor of mortality in kidney transplant patients, a study found.
Immunosuppression To Fit the Patient
Researchers have identified a gene signature that may enable clinicians to distinguish which renal transplant recipients could be eligible for a progressive decrease in their immunosuppressive medications and who needs to stay on their current dose.
Pre-Existing CAD Worsens Tx Outcomes
Pre-existing coronary artery disease (CAD) decreases survival of patients following renal transplantation, study findings suggest.
LVH Reversible After Transplantation
Prolonged ACE inhibitor treatment can reverse left ventricular hypertrophy (LVH) in renal transplant recipients receiving cyclosporine-based immunosuppression, according to researchers.
- Loading...
Loading...
Loading... 
Loading...